Exchange: NYSE·Updated 07:34 PM EDT
News
all
press releases
CONMED Q2 Earnings and Revenues Beat Estimates, Gross Margin Expands
CNMD's Q2 earnings and revenues beat estimates, while margin growth and solid international sales support a higher 2026 EPS outlook.
Zacks
More News
Conmed (CNMD) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Conmed (CNMD) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks
Conmed (CNMD) Q2 Earnings and Revenues Top Estimates
Conmed (CNMD) delivered earnings and revenue surprises of +25.46% and +1.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
CONMED Corporation Reports Second Quarter 2026 Financial Results; Updates Full Year 2026 Guidance
CONMED Corporation (NYSE: CNMD) today reported financial results for the second quarter ended June 30, 2026 and updated its financial guidance for the full year ending 2026. Second Quarter 2026 Highlights(1) Sales of $343.5 million increased 0.3% year-over-year as reported and decreased 0.5% on a...
Business Wire
CONMED Expands AirSeal Robotic Solution for da Vinci 5 Hex Cannula
CNMD's FDA-expanded AirSeal indication adds da Vinci 5 hex cannula compatibility, supporting broader use across Intuitive Surgical's robotic systems.
Zacks
CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal Robotic Solution for Use with the Intuitive da Vinci 5 Hex Cannula
CONMED Corporation (NYSE: CNMD) today announced that its AirSeal Robotic Solution is now indicated for use with Intuitives 8 mm hex cannulas used as part of the Intuitive da Vinci 5 platform (dV5). Alongside its existing indication for Intuitive 8 mm round cannulas, the AirSeal Robotic Solution now...
Business Wire
CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting
CONMED Corporation (NYSE: CNMD) today announced its participation in the Society of Robotic Surgery (SRS) 2026 Annual Meeting, which is being held July 23-26, 2026 in Fort Lauderdale, FL. During the meeting, Professor Nikhil Vasdev, FRCS (Urol), MCh (Urol), DSc will present data from a prospective...
Business Wire
CNMD Crosses Above Average Analyst Target
In recent trading, shares of CONMED Corp (Symbol: CNMD) have crossed above the average analyst 12-month target price of $38.57, changing hands for $42.41/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuatio...
Nasdaq News: Markets
CNMD Stock Hits Highest Level In Over Four Months – Why JPMorgan Believes Firm Would Be Highly Attractive To ‘Financial Acquirers’
On Friday, a Bloomberg Law report indicated that the company is considering a sale after private equity investors expressed interest.
Stocktwits
CNMD Stock Surges As Much As 10% After-Hours On Reports Of Private Equity Takeover Interest
The medical technology company is working with advisers to evaluate strategic options, Bloomberg Law reported, citing people familiar with the matter.
Stocktwits
<
1
2
>

Advertisement|Remove ads.